Calcimycin induced IL-12 production inhibits intracellular mycobacterial growth by enhancing autophagy.
Previously, we reported pivotal role of P2RX7 in augmenting autophagy in THP-1 cells upon Calcimycin treatment by modulating intracellular Calcium regulated ATP production but the role of immune modulators in Calcimycin induced autophagy is not known. In this study, we demonstrate that treatment with Calcimycin in PMA (Phorbol 12-myristate 13-acetate) differentiated THP-1 (dTHP-1) cells significantly induced interleukin (IL)-12 mRNA expression and its release. IL-12 receptor (IL-12Rβ1 and IL-12Rβ2) was also significantly expressed on the cell surface in dTHP-1 cells upon Calcimycin treatment. We report that small molecule or siRNA based P2RX7 inhibition abrogated IL-12 release upon Calcimycin treatment. P2RX7 inhibition also resulted in reduced Jun N-terminal kinase (JNK) activation, IκBα phosphorylation, p65 translocation and NF-κB expression. Further, inhibition of NF-κB activation or IL-12-IL-12R interaction led to down-regulation of the expression of autophagy related markers such as Beclin-1, autophagy-related gene (Atg) 3, Atg 7 and impairment of microtubule-associated protein 1A/1B-light chain 3-I (LC3-I) to LC3-II conversion. Finally, blocking of autophagy led to significant growth of intracellular mycobacteria in Calcimycin treated macrophages. Overall, these results reveal that interaction of Calcimycin with P2RX7 modulates intracellular JNK-NF-κB signaling pathway. This modulation results in IL-12 release that restricts the mycobacterial growth in THP-1 macrophages.